135 related articles for article (PubMed ID: 22965833)
21. Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms.
Xing Z; Su A; Mi L; Zhang Y; He T; Qiu Y; Wei T; Li Z; Zhu J; Wu W
Drug Des Devel Ther; 2023; 17():2909-2929. PubMed ID: 37753228
[TBL] [Abstract][Full Text] [Related]
22. The Therapeutic Effects of Withaferin A against Cancer: Overview and Updates.
Abeesh P; Guruvayoorappan C
Curr Mol Med; 2024; 24(4):404-418. PubMed ID: 37076466
[TBL] [Abstract][Full Text] [Related]
23. Modulation of Notch Signaling Pathway by Bioactive Dietary Agents.
Kiesel VA; Stan SD
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408894
[TBL] [Abstract][Full Text] [Related]
24.
Kashyap VK; Peasah-Darkwah G; Dhasmana A; Jaggi M; Yallapu MM; Chauhan SC
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335986
[TBL] [Abstract][Full Text] [Related]
25. A Low Dose Combination of Withaferin A and Caffeic Acid Phenethyl Ester Possesses Anti-Metastatic Potential In Vitro: Molecular Targets and Mechanisms.
Sari AN; Dhanjal JK; Elwakeel A; Kumar V; Meidinna HN; Zhang H; Ishida Y; Terao K; Sundar D; Kaul SC; Wadhwa R
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159054
[TBL] [Abstract][Full Text] [Related]
26. Withaferin A: From Ancient Remedy to Potential Drug Candidate.
Sultana T; Okla MK; Ahmed M; Akhtar N; Al-Hashimi A; Abdelgawad H; Haq IU
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946778
[TBL] [Abstract][Full Text] [Related]
27. Critical review of the
Afewerky HK; Ayodeji AE; Tiamiyu BB; Orege JI; Okeke ES; Oyejobi AO; Bate PNN; Adeyemi SB
Bull Natl Res Cent; 2021; 45(1):176. PubMed ID: 34697529
[TBL] [Abstract][Full Text] [Related]
28. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
[TBL] [Abstract][Full Text] [Related]
29. Withaferin A inhibits lysosomal activity to block autophagic flux and induces apoptosis via energetic impairment in breast cancer cells.
Muniraj N; Siddharth S; Nagalingam A; Walker A; Woo J; Győrffy B; Gabrielson E; Saxena NK; Sharma D
Carcinogenesis; 2019 Sep; 40(9):1110-1120. PubMed ID: 30698683
[TBL] [Abstract][Full Text] [Related]
30. Peptidyl-prolyl cis/trans isomerase Pin1 regulates withaferin A-mediated cell cycle arrest in human breast cancer cells.
Samanta SK; Lee J; Hahm ER; Singh SV
Mol Carcinog; 2018 Jul; 57(7):936-946. PubMed ID: 29603395
[TBL] [Abstract][Full Text] [Related]
31. Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer.
Yadav DK; Kumar S; Saloni ; Singh H; Kim MH; Sharma P; Misra S; Khan F
Drug Des Devel Ther; 2017; 11():1859-1870. PubMed ID: 28694686
[TBL] [Abstract][Full Text] [Related]
32. Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation.
Daley-Brown D; Oprea-Iles G; Vann KT; Lanier V; Lee R; Candelaria PV; Quarshie A; Pattillo R; Gonzalez-Perez RR
Dis Markers; 2017; 2017():8248175. PubMed ID: 28659656
[TBL] [Abstract][Full Text] [Related]
33. Withaferin A protects against spinal cord injury by inhibiting apoptosis and inflammation in mice.
Yan X; Huang G; Liu Q; Zheng J; Chen H; Huang Q; Chen J; Huang H
Pharm Biol; 2017 Dec; 55(1):1171-1176. PubMed ID: 28228044
[TBL] [Abstract][Full Text] [Related]
34. Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.
Samanta SK; Sehrawat A; Kim SH; Hahm ER; Shuai Y; Roy R; Pore SK; Singh KB; Christner SM; Beumer JH; Davidson NE; Singh SV
J Natl Cancer Inst; 2017 Jun; 109(6):. PubMed ID: 28040797
[TBL] [Abstract][Full Text] [Related]
35. Natural Withanolides in the Treatment of Chronic Diseases.
White PT; Subramanian C; Motiwala HF; Cohen MS
Adv Exp Med Biol; 2016; 928():329-373. PubMed ID: 27671823
[TBL] [Abstract][Full Text] [Related]
36. Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown.
Kim SH; Hahm ER; Arlotti JA; Samanta SK; Moura MB; Thorne SH; Shuai Y; Anderson CJ; White AG; Lokshin A; Lee J; Singh SV
Breast Cancer Res Treat; 2016 May; 157(1):41-54. PubMed ID: 27097807
[TBL] [Abstract][Full Text] [Related]
37. Vimentin, colon cancer progression and resistance to butyrate and other HDACis.
Lazarova DL; Bordonaro M
J Cell Mol Med; 2016 Jun; 20(6):989-93. PubMed ID: 27072512
[TBL] [Abstract][Full Text] [Related]
38. Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of Action.
Lee IC; Choi BY
Int J Mol Sci; 2016 Mar; 17(3):290. PubMed ID: 26959007
[TBL] [Abstract][Full Text] [Related]
39. Pharmacologic overview of Withania somnifera, the Indian Ginseng.
Dar NJ; Hamid A; Ahmad M
Cell Mol Life Sci; 2015 Dec; 72(23):4445-60. PubMed ID: 26306935
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
